Dr Reddys Laboratories (RDY) Non Operating Interest Expenses (2013 - 2016)
Dr Reddys Laboratories (RDY) posted quarterly Non Operating Interest Expenses of $41.0 million for Q4 2016, up 925.0% quarter-over-quarter from $4.0 million in Q1 2013.
Dr Reddys Laboratories (RDY) Non Operating Interest Expenses (2013 - 2016) Analysis & Trends
Dr Reddys Laboratories' Non Operating Interest Expenses history runs 2 years deep, the most recent figure standing at $41.0 million for Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 41.00 Mn |
| Mar 31, 2013 | 4.00 Mn |